Asunto(s)
Neurología/tendencias , Pediatría , Niño , Educación , Educación Médica/normas , Humanos , Japón , Neurología/ética , Médicos , Sociedades CientíficasRESUMEN
Growth hormone (GH) therapy for short stature in patients with Prader-Willi syndrome (PWS) has started worldwide, and various favorable effects have been reported. However, the possibility of progression of scoliosis arises as a new problem of the GH therapy. In this study, we analyzed whether 72 patients who have been followed up in our hospital have such a problem. They included 46 males and 26 females (41 patients with the GH therapy and 31 without it) aged from one to 49 years. Consequently, 33 (45.8%) of 72 patients had scoliosis with the Cobb angle of >10 degrees. Twenty (48.8%) of forty-one patients who received a GH therapy and 13 (41.9%) of 31 patients without the therapy had scoliosis, the frequency of scoliosis between the two groups showing no statistical difference (P = 0.56). Height velocity of scoliotic and non-scoliotic patients during the first year of the therapy was 8.59 +/- 1.92 and 10.70 +/- 2.54 cm, respectively, showing a significant difference (P < 0.001). This shows that accelerated height velocity may not induce scoliosis. Comparison of starting age of a GH treatment revealed that non-scoliotic patients received the therapy earlier than scoliotic patients (P = 0.021). Among 20 scoliotic patients who received the GH therapy, the degree of scoliosis progressed during the therapy in six patients, improved in three and fluctuated in one. Many patients showed progression of scoliosis with age irrespective of the use of GH, and some patients improved their scoliosis during the GH therapy. These findings showed that a GH therapy increases height velocity of PWS patients but does not necessarily develop scoliosis, and early start of the therapy may not be an exacerbating factor of scoliosis.
Asunto(s)
Hormona del Crecimiento/uso terapéutico , Síndrome de Prader-Willi/complicaciones , Síndrome de Prader-Willi/tratamiento farmacológico , Escoliosis/complicaciones , Escoliosis/tratamiento farmacológico , Adolescente , Adulto , Niño , Preescolar , Progresión de la Enfermedad , Femenino , Humanos , Lactante , Masculino , Síndrome de Prader-Willi/genética , Radiografía , Escoliosis/diagnóstico por imagen , Escoliosis/genética , Escoliosis/metabolismoRESUMEN
Patients with Prader-Willi syndrome (PWS) are recognized to have a tendency of sudden, unexpected death (SED), but its exact cause is unknown because of paucity of such case reports. Since growth hormone (GH) treatment was applied to PWS patients worldwide, several cases of death have been reported. However, whether the therapy is directly related to their SED remains unknown, too. We collected 13 deceased PWS patients (Group A, aged 9 months to 34 years) who had never received GH therapy, and seven deceased patients (Group B, all boys aged 0.7-15 years) having received the therapy from the registration in PWS-patient-support associations and from the literature, respectively. We then compared the cause of SED between the two groups. Irrespective of GH therapy, SED of infants under age 1 year was associated with milk aspiration or hypothalamic dysregulation of respiration, while SED of patients in early childhood or adolescence occurred at sleeping in association with preceding viral infections. In contrast, SED of four adult (>20 years of age) patients who never received GH therapy was associated with complications, such as leg cellulites and pulmonary embolism, secondary to massive obesity and diabetes mellitus (DM). Two Group-B patients (aged 14 and 20 years) without any obesity-related or diabetes-related complications died of drowning in a bath tub, and their drowning death could be related to poor respiratory control. These findings indicated that the cause of SED is not essentially different between PWS patients with and without GH treatment. Deceased PWS patients may have had underlying respiratory dysregulation and hypothalamic dysfunction, and GH therapy might have led to certain obstructive respiratory disturbances that exacerbated the respiratory conditions. This will call clinicians' attention when using GH in PWS patients, for example, careful determination of the dose of GH and careful monitoring of patient's respiratory conditions, especially in male obese patients with respiratory problems.
Asunto(s)
Muerte Súbita/etiología , Hormona del Crecimiento/uso terapéutico , Síndrome de Prader-Willi/complicaciones , Adolescente , Adulto , Factores de Edad , Causas de Muerte , Niño , Preescolar , Diarrea/complicaciones , Femenino , Humanos , Lactante , Masculino , Síndrome de Prader-Willi/tratamiento farmacológico , Síndrome de Prader-Willi/mortalidad , Embolia Pulmonar/complicaciones , Virosis/complicacionesRESUMEN
BACKGROUND: Dysembryoplastic neuroepithelial tumors (DNTs) are associated with medically intractable epilepsy and a favorable prognosis after surgical resection. The authors describe the clinical, radiologic, and pathologic characteristics and outcomes in children after surgical resection of pathologically confirmed DNT to ascertain prognostic features for seizure recurrence following surgery. METHODS: Neurology, neurosurgery, and pathology databases from 1993 to 2002 at the Hospital for Sick Children were searched to retrospectively identify children with confirmed DNT and presentation with seizures. Risk factors for postoperative seizure recurrence were examined with respect to seizure outcome at 12 months and long-term follow-up. RESULTS: Of the 26 children identified (mean age at surgery 10.0 years) seizure outcome was good in 22 children (85%) at 12 months (Class 1). At longer follow-up (mean 4.3, range 1.0 to 11.0 years) only 16 (62%) remained seizure-free. Residual DNT was evident in 15 of the 24 children with available postoperative MRI. Three children demonstrated recurrence of tumor. At 12 months follow-up, older age (>10 years) and longer duration of epilepsy (>2 years) were associated with seizure recurrence. The presence of residual tumor was a risk factor for seizure recurrence at long-term follow-up (p = 0.02). CONCLUSIONS: Children with DNT and epilepsy may benefit from surgical management; however, seizure outcome is not always favorable. Although the majority of children remain seizure free after surgical excision of DNT, a considerable number have recurrent seizures. Short-term outcome is influenced by older age at surgery and longer duration of epilepsy. Residual tumor is a significant risk factor for poor seizure outcome. Recurrent tumor can occur.
Asunto(s)
Neoplasias Encefálicas/complicaciones , Neoplasias Encefálicas/cirugía , Epilepsia/etiología , Epilepsia/cirugía , Neoplasias Neuroepiteliales/complicaciones , Neoplasias Neuroepiteliales/cirugía , Adolescente , Neoplasias Encefálicas/diagnóstico , Niño , Preescolar , Femenino , Humanos , Masculino , Neoplasias Neuroepiteliales/diagnóstico , Pronóstico , Recurrencia , Resultado del TratamientoRESUMEN
Walker-Warburg syndrome (WWS) is a congenital muscular dystrophy associated with neuronal migration disorder and structural eye abnormalities. The mutations in the O-mannosyltransferase 1 gene (POMT1) were identified recently in 20% of patients with WWS. The authors report on a patient with WWS and a novel POMT1 mutation. Their patient expressed alpha-dystroglycan (alpha-DG) core protein, but fully glycosylated alpha-DG antibody epitopes were absent, associated with the loss of laminin-binding activity.
Asunto(s)
Encéfalo/anomalías , Anomalías del Ojo/genética , Manosiltransferasas/genética , Distrofias Musculares/genética , Malformaciones del Sistema Nervioso/genética , Anomalías Múltiples/genética , Potenciales de Acción , Encéfalo/patología , Preescolar , Secuencia Conservada , Creatina Quinasa/sangre , Proteínas del Citoesqueleto/deficiencia , Proteínas del Citoesqueleto/metabolismo , Análisis Mutacional de ADN , Distroglicanos , Electroencefalografía , Humanos , Immunoblotting , Inmunohistoquímica , Japón , Imagen por Resonancia Magnética , Masculino , Glicoproteínas de Membrana/deficiencia , Glicoproteínas de Membrana/metabolismo , Distrofias Musculares/congénito , Malformaciones del Sistema Nervioso/diagnóstico , SíndromeAsunto(s)
Enfermedad de Leigh/etiología , ADN Mitocondrial/genética , Diagnóstico Diferencial , Genes Recesivos , Ligamiento Genético , Humanos , Enfermedad de Leigh/terapia , Mutación Puntual , Pronóstico , Enfermedad por Deficiencia del Complejo Piruvato Deshidrogenasa/complicaciones , Cromosoma XAsunto(s)
Miopatías Mitocondriales , Niño , Deficiencia de Citocromo-c Oxidasa , Complejo I de Transporte de Electrón , Complejo II de Transporte de Electrones , Complejo III de Transporte de Electrones/deficiencia , Humanos , Ácido Láctico/sangre , Masculino , Miopatías Mitocondriales/clasificación , Miopatías Mitocondriales/fisiopatología , Complejos Multienzimáticos/deficiencia , Músculos/patología , NADH NADPH Oxidorreductasas/deficiencia , Oxidorreductasas/deficiencia , Ácido Pirúvico/sangre , Succinato Deshidrogenasa/deficienciaAsunto(s)
Anorexia Nerviosa/genética , Proteínas Portadoras/genética , Glicoproteínas de Membrana/genética , Proteínas de Transporte de Membrana , Proteínas del Tejido Nervioso , Polimorfismo Genético , Adolescente , Alelos , Femenino , Humanos , Proteínas de Transporte de Serotonina en la Membrana PlasmáticaAsunto(s)
Anorexia Nerviosa/sangre , Serotonina/sangre , Adolescente , Adulto , Niño , Femenino , Humanos , MasculinoRESUMEN
We report here three infants with frequent convulsions in the post-eruptive stage of exanthem subitum (ES) due to human herpesvirus 6 (HHV-6) infection. Postictal electroencephalogram (EEG) showed in all the patients abnormal epileptic discharges, which disappeared in the following by three to eighteen months. In one case, brain magnetic resonance imaging (MRI) revealed focal gliosis. SPECT demonstrated hypoperfusion of the lesion. In the cerebro spinal fluid (CSF) of all the patients, HHV-6 DNA was negative on polymerase chain reaction (PCR) and HHV-6 antibodies were not significantly increased. Although encephalitis has been reported to complicate primary HHV-6 infection, our patients were not diagnosed as having encephalitis because of the clinical, CSF, EEG and CT findings. However, they had frequent convulsions. Not only virus invasion but also a secondary reaction including vasculitis may cause the central nervous system complications of HHV-6 infection. Frequent convulsions may occur in the post-eruptic stage after HHV-6 infection.
Asunto(s)
Exantema Súbito/complicaciones , Convulsiones/etiología , Electroencefalografía , Exantema Súbito/fisiopatología , Femenino , Humanos , Lactante , MasculinoRESUMEN
We morphometrically measured the cut surface of the cerebral hemisphere and localized epidermal growth factor (EGF)-like immunoreactivity in 4 patients with hemimegalencephaly. On the affected side, the area of cerebral white matter was more than twice as large as that on the unaffected side, while the area of the cerebral cortex on the affected side was relatively small. EGF-like immunoreactivity was demonstrated in cortical neurons (4 of 4 patients) and glial cells (3 of 4 patients), notably in astrocytes. Significant enlargement of the cerebral white matter compared to the cerebral cortex and the expression of EGF-like molecules in astrocytes suggest excessive proliferation in the white matter with hemimegalencephaly and the possible relevance of EGF to these events.
Asunto(s)
Encéfalo/patología , Factor de Crecimiento Epidérmico/análisis , Encéfalo/anomalías , Encéfalo/metabolismo , Niño , Preescolar , Femenino , Humanos , Hipertrofia , Técnicas para Inmunoenzimas , Lactante , MasculinoRESUMEN
Holocarboxylase synthetase (HCS) deficiency is an inherited disease of biotin metabolism characterized by a unique pattern of organic aciduria, metabolic acidosis, and skin lesions. By analysis of five patients in four unrelated families, two mutations were identified: a transition from T to C which causes an amino-acid substitution of proline for leucine at position 237 (L237P) and a single deletion of guanine (delG1067) followed by premature termination. One patient was homozygous for the L237P mutation, three patients in two families were compound heterozygotes of the missense and deletion alleles, and the other patient was heterozygous for the L237P mutation. Inheritance was successfully demonstrated in all of the patients' families by a modified PCR followed by restriction enzyme digestion. The two mutations accounted for seven of eight mutant alleles, while neither mutation was detected in 108 normal healthy Japanese children (216 alleles). Transient expression in cultured fibroblasts from a patient showed that the L237P mutation was responsible for decreased HCS activity. These results suggest that the L237P and delG1067 mutations are frequent disease-causing mutations in Japanese patients with HCS deficiency. This PCR-based technique may therefore be useful for detecting mutations among Japanese patients.
Asunto(s)
Biotina/metabolismo , Ligasas de Carbono-Nitrógeno , Ligasas/deficiencia , Ligasas/genética , Errores Innatos del Metabolismo/genética , Secuencia de Aminoácidos , Secuencia de Bases , Western Blotting , Cartilla de ADN , Femenino , Genotipo , Heterocigoto , Homocigoto , Humanos , Recién Nacido , Japón , Masculino , Datos de Secuencia Molecular , Linaje , Mutación Puntual , Análisis de Secuencia , Eliminación de Secuencia , TransfecciónRESUMEN
Ten patients, two men and eight women with mitochondrial encephalomyopathy, had an A-G mutation at nucleotide pair 8,344 in the mitochondrial DNA, the most common genetic defect in myoclonus epilepsy with ragged-red fibers (MERRF). Eight patients had the clinical and pathologic characteristics of MERRF including myoclonus, seizures, cerebellar ataxia and myopathy with ragged-red fibers. Two patients had atypical symptoms such as early onset of fatal cardiac failure and late onset of rapid mental deterioration, respectively. The striking feature in our patients with the 8,344 mutation cardiac involvement and two developed progressive heart failure. In the typical MERRF patients, the proportion of mutant mitochondrial DNA in their skeletal muscles, quantified by a single strand conformation polymorphism analysis, was above 85%. However, there was no significant correlation between clinical severity, histopathological findings and the proportion of mutant mtDNA in muscle biopsy samples, suggesting that non-ragged-red fibers play an important role in the phenotype expression of the mutants.
Asunto(s)
Análisis Mutacional de ADN , ADN Mitocondrial/genética , Encefalomiopatías Mitocondriales/genética , Adolescente , Adulto , Secuencia de Bases , Niño , Preescolar , ADN Mitocondrial/análisis , ADN Mitocondrial/metabolismo , Complejo IV de Transporte de Electrones/genética , Complejo IV de Transporte de Electrones/metabolismo , Femenino , Histocitoquímica , Humanos , Lactatos/sangre , Ácido Láctico , Masculino , Persona de Mediana Edad , Encefalomiopatías Mitocondriales/metabolismo , Datos de Secuencia Molecular , Músculo Esquelético/enzimología , Músculo Esquelético/metabolismo , Fenotipo , Reacción en Cadena de la Polimerasa , Piruvatos/sangre , Ácido PirúvicoRESUMEN
A 50-year-old woman with subacute dementia and brain atrophy on CT showed periodic synchronous discharge (PSD) on electroencephalogram (EEG) and myoclonus. She was initially suspected of suffering from Creutzfeldt-Jakob disease (CJD), but dramatically recovered over 5 months. Based on further investigations, the final diagnosis was mitochondrial encephalomyopathy with an A-to-G substitution at nucleotide position 3243 in mitochondrial DNA (mtDNA), commonly seen in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). This case suggests that patients suspected of suffering from CJD should be evaluated for mitochondrial encephalomyopathy.